FDA’s FY2025 data shows that 78% of 1,309 drug quality inspections led to voluntary or official action classifications. Therefore, manufacturers can no longer rely on disconnected spreadsheets, delayed CAPA follow-up, or weak document control. Pharmaceutical QMS software connects quality processes, strengthens audit trails, and gives inspectors clear evidence of control. Moreover, the right pharma quality management software supports GMP compliance, system validation, and faster inspection readiness.
Table of Contents
What Is Pharmaceutical QMS Software?
Pharmaceutical QMS software is a validated electronic system that helps manufacturers control GMP records, quality processes, approvals, and compliance evidence in one secure environment. It manages documents, deviations, CAPA, change controls, training, and audit trails throughout the quality lifecycle. Moreover, an electronic quality management system assigns responsibilities, tracks deadlines, and records each user action. Therefore, teams can maintain data integrity, reduce manual errors, and present clear evidence during regulatory inspections.
Why eQMS Controls Matter During GMP Inspections
eQMS controls help pharmaceutical companies keep GMP records complete, secure, traceable, and ready for inspection. The system records each approval, revision, user action, and deadline within a controlled workflow. Moreover, eQMS software for pharma strengthens audit trails, access control, and data integrity across quality processes. Therefore, inspectors can follow each decision, verify accountability, and confirm that the company maintains consistent control over its quality system.
The following infographic shows how a pharmaceutical eQMS connects GMP records, approvals, audit trails, CAPA, and compliance evidence to support inspection readiness.
Four Regulatory Controls That Define an Inspection-Ready eQMS
An inspection-ready eQMS must control quality decisions, electronic records, system validation, and data integrity throughout the GMP lifecycle. Moreover, these controls help teams prove accountability, maintain traceability, and respond quickly during regulatory inspections. The following four areas form the regulatory foundation of a compliant pharmaceutical quality management system:
- CAPA and Change Management Workflows (PDF)
- Electronic Records and Electronic Signatures (PDF)
- Computerized System Validation and Lifecycle Control (PDF)
- Audit Trail Review and Data Integrity Governance (PDF)
CAPA and Change Management Workflows (PDF)
An eQMS connects deviations, CAPA, effectiveness checks, and change controls in one traceable workflow. Moreover, it records responsibilities, approvals, deadlines, and risk-based decisions.
Download ICH Q10: CAPA and Change Management in Pharmaceutical Quality Systems Here
Electronic Records and Electronic Signatures (PDF)
An eQMS protects electronic GMP records and links each approval to a verified user, date, and time. Therefore, teams can maintain secure, attributable, and traceable compliance evidence.
Download Part 11, Electronic Records; Electronic Signatures — Scope and Application Here
Computerized System Validation and Lifecycle Control (PDF)
Computerized system validation confirms that the eQMS performs its intended GMP functions accurately and consistently. In addition, lifecycle controls manage requirements, testing, changes, periodic review, and system retirement.
Download Good Practices for Computerised Systems in Regulated GXP Environments — PI 011-3
Audit Trail Review and Data Integrity Governance (PDF)
Audit trails record who changed GMP data, what changed, and when the action occurred. Therefore, quality teams can review critical activities, investigate unusual changes, and protect data integrity.
Core eQMS Features for Pharmaceutical Quality Systems
A pharmaceutical eQMS should do more than replace paper forms. It should connect quality events, approvals, responsibilities, and compliance records across the product lifecycle. Moreover, each module should support a defined GMP control and produce clear evidence that inspectors can review quickly.
The following table connects essential eQMS features with their GMP objectives and expected inspection evidence:
| eQMS Feature | GMP Control Objective | Expected Inspection Evidence |
|---|---|---|
|
Document Control |
Ensure employees use current and approved GMP procedures. |
Version history, approval records, effective dates, electronic signatures, and obsolete-document controls. |
|
Deviation and CAPA Management |
Investigate quality events, correct root causes, and prevent recurrence. |
Deviation records, root cause analyses, CAPA plans, assigned owners, due dates, and effectiveness checks. |
|
Change Control |
Assess and approve changes before they affect product quality or validated systems. |
Change requests, risk assessments, validation actions, impact reviews, approvals, and closure evidence. |
|
Audit Trail and Access Control |
Protect electronic records and maintain secure, attributable, and traceable user activity. |
User-role lists, access reviews, audit trail reports, security logs, and electronic signature records. |
How to Validate Pharmaceutical QMS Software
Pharmaceutical companies should validate QMS software through a risk-based lifecycle that starts with intended use and approved user requirements. Next, teams should assess critical functions, test configured workflows, verify data integrity controls, and document traceability between requirements and results. Moreover, change control, periodic review, and incident management help maintain the validated state. Therefore, a validated eQMS can consistently perform its intended GMP functions and provide reliable inspection evidence.
The following infographic explains how risk-based validation connects intended use, system requirements, testing, traceability, and lifecycle controls to maintain a compliant pharmaceutical eQMS.
Final Words
In FY2025, FDA issued 970 drug-facility inspection classification letters and more than 125 warning letters. Therefore, pharmaceutical companies must maintain complete records, timely CAPA actions, and reliable data controls before inspectors arrive. Pharmaceutical QMS software can connect these controls and provide clear evidence of consistent GMP oversight. Ultimately, companies that validate and manage their eQMS throughout its lifecycle can reduce compliance gaps and strengthen inspection readiness.
Digital Solutions for GMP Operations
We support pharmaceutical teams in implementing, maintaining, and optimizing GMP software, data management systems, and computerized workflows that strengthen compliance, data integrity, and operational efficiency.
FAQ
Inspectors usually check document control, user access, audit trails, electronic signatures, overdue CAPA, and evidence that the system remains validated.
Companies should set the review frequency through documented risk assessment. However, they must also review the system after major changes, recurring incidents, or significant compliance issues.
Common failures include incomplete validation, weak audit trail review, excessive user access, uncontrolled configuration changes, missing traceability, and overdue CAPA actions.
References
Reza Esmaeili is a technology and product leader in Germany, combining CTO and CPO experience to bridge engineering execution with customer-driven product strategy. He has led cloud and automation initiatives that improved operational efficiency and reduced costs. He has managed cross-functional teams of engineers and product managers and brought new software products from concept to market. He focuses on building data-driven product organizations by introducing analytics to track performance and guide decisions. He champions Agile ways of working to shorten feedback loops, improve quality, and accelerate go-to-market execution in close partnership with sales and marketing.